We have been screening in vitro microbial products which could be preferentially active against ras oncogene-expressed cells. For this purpose, we are using a rat kidney cell line integrating temperature-sensitive v-K-ras (rasts NRK), grown either at 33°C (a permissive temperature) or at 39°C (a nonpermissive temperature)1}.
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The cells grown under the former and latter conditions are referred to as ras+ and ras~cells, respectively. We found that a strain of streptomyces produced a metabolite which altered the morphology of ras+ cells into something like that of ras~cells (Fig. 1) . The active component was isolated and the structure was determined. The studies revealed that the active componentwasa newantibiotic, structurally related to leptomycin A2). We report here the production, isolation, physico-chemical and some biological properties of this antibiotic. The producing microorganism, isolated from a soil sample collected at Shinagawa-ku, Tokyo, Japan was classified as Streptomyces sp. MJ132-NF5. From an agar slant culture of this strain, mycelial specimens were taken and inoculated into two 500-ml Erlenmeyer flasks each containing 110ml of a mediumcomposedof meat extract Phase-contrast microscopies, rasts NRKcells were grown as reported (1) After 2 days of fermentation at 27°C on a rotary shaker, about 2 ml portions of the seed culture were transferred to 90 flasks of the same type each containing 110ml of the same medium. Fermentation was continued for 4 days under the same conditions as for the seed culture. Throughout the purification procedures described below, the active material was chased by monitoring the activity converting the cell morphology of rasts NRK The mycelia (390g, wet) were collected on a filter and extracted with MeOH (1.5 liters x 2). The extract was concentrated in vacuo and the resulting solution (100 ml) was stirred with 2 liters of EtOAc. The EtOAc layer was taken and evaporated in vacuo, leaving an oily residue (3.2g) which was applied to a silica gel column (5 x 30cm in CHC13 rial are summarized in Table 1 . The molecular formula was determined to be C32H48O5 by HRFAB-MS. UVabsorption maxima in neutral ethanol are at 204nm (e 25,000), 240nm (27,000) and 295nm (3, 700) . XH NMRand 13C NMRdata are summarized in Table 2 . The assignments are in accord with those for leptomycins2), except an alcohol group at the carbon position number 24, which is replaced by a carboxyl group in leptomycin A (Fig. 2) . Because of the structural similarity, we tentatively namethis compoundreductoleptomycin A (RLA reported to act on progression of both Gl and G2 APR. 1993 in the eukaryotic cell cycle4).
